Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This pilot phase II trial studies how well giving bortezomib and cyclophosphamide together
with chloroquine works in treating patients with relapsed or refractory multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health